Montse Verdú

Summary

Publications

  1. doi request reprint ERG expression and prostatic adenocarcinoma
    Montse Verdú
    BIOPAT, Biopatologia Molecular, Grup Assistencia, Avda Diagonal 660, Planta 1, 08034 Barcelona, Spain
    Virchows Arch 462:639-44. 2013
  2. doi request reprint Clinicopathological and molecular characterization of colorectal micropapillary carcinoma
    Montse Verdú
    BIOPAT, Biopatologia Molecular SL, Grup Assistencia, Barcelona, Spain
    Mod Pathol 24:729-38. 2011
  3. ncbi request reprint A novel logistic model based on clinicopathological features predicts microsatellite instability in colorectal carcinomas
    Anna Colomer
    BIOPAT, Grup Assistencia, Barcelona, Spain
    Diagn Mol Pathol 14:213-23. 2005
  4. ncbi request reprint Lack of p53 nuclear immunostaining is not indicative of absence of TP53 gene mutations in colorectal adenocarcinomas
    Anna Colomer
    BIOPAT, Grup Assistencia, Barcelona, Spain
    Appl Immunohistochem Mol Morphol 11:130-7. 2003
  5. pmc A novel multiplexing, polymerase chain reaction-based assay for the analysis of chromosome 18q status in colorectal cancer
    Nadina Erill
    BIOPAT, Universitat de Barcelona, Spain
    J Mol Diagn 7:478-85. 2005
  6. doi request reprint Microsatellite instability of the colorectal carcinoma can be predicted in the conventional pathologic examination. A prospective multicentric study and the statistical analysis of 615 cases consolidate our previously proposed logistic regression model
    Ruth Roman
    BIOPAT Biopatologia Molecular, SL, Grup Assistencia, Avda Diagonal 660, Barcelona, Spain
    Virchows Arch 456:533-41. 2010

Collaborators

Detail Information

Publications6

  1. doi request reprint ERG expression and prostatic adenocarcinoma
    Montse Verdú
    BIOPAT, Biopatologia Molecular, Grup Assistencia, Avda Diagonal 660, Planta 1, 08034 Barcelona, Spain
    Virchows Arch 462:639-44. 2013
    ..Thus, detecting ERG using immunohistochemistry may be useful in routine practice in pathology departments...
  2. doi request reprint Clinicopathological and molecular characterization of colorectal micropapillary carcinoma
    Montse Verdú
    BIOPAT, Biopatologia Molecular SL, Grup Assistencia, Barcelona, Spain
    Mod Pathol 24:729-38. 2011
    ..The molecular profile supports the hypothesis that micropapillary carcinoma carcinogenesis develops through the classical chromosomal instability pathway...
  3. ncbi request reprint A novel logistic model based on clinicopathological features predicts microsatellite instability in colorectal carcinomas
    Anna Colomer
    BIOPAT, Grup Assistencia, Barcelona, Spain
    Diagn Mol Pathol 14:213-23. 2005
    ..It will also assist in identifying a subset of patients likely to benefit from adjuvant chemotherapy...
  4. ncbi request reprint Lack of p53 nuclear immunostaining is not indicative of absence of TP53 gene mutations in colorectal adenocarcinomas
    Anna Colomer
    BIOPAT, Grup Assistencia, Barcelona, Spain
    Appl Immunohistochem Mol Morphol 11:130-7. 2003
    ..It is thus concluded that molecular profiling should be conducted in parallel with immunophenotyping when analyzing colorectal tumors for p53 status...
  5. pmc A novel multiplexing, polymerase chain reaction-based assay for the analysis of chromosome 18q status in colorectal cancer
    Nadina Erill
    BIOPAT, Universitat de Barcelona, Spain
    J Mol Diagn 7:478-85. 2005
    ....
  6. doi request reprint Microsatellite instability of the colorectal carcinoma can be predicted in the conventional pathologic examination. A prospective multicentric study and the statistical analysis of 615 cases consolidate our previously proposed logistic regression model
    Ruth Roman
    BIOPAT Biopatologia Molecular, SL, Grup Assistencia, Avda Diagonal 660, Barcelona, Spain
    Virchows Arch 456:533-41. 2010
    ....